Mnemosyne Pharmaceuticals Inc

Amendment
CIK: 0001542171·Biotechnology·DELAWARE·Filed: Jul 3, 2013
Total Offering

$11,384,496

Amount Sold

$8,384,496

Investors

6

First Sale

Feb 1, 2012

Offering Details

Type
Equity
Exemptions
Rule 506
Entity Type
Corporation
Year Incorporated
2010
Non-Accredited Investors
No

Related Persons

NameRole
Kollol Pal
Related Person
Frank Menniti
Related Person
Richard Horan
Related Person
James Bristol
Related Person
Peter Barrett
Related Person
William Koster
Related Person

Company

Mnemosyne Pharmaceuticals Inc

ONE DAVOL SQUARE

PROVIDENCE, RI, 02903

401-632-0383

SEC Filing

0000908662-13-000253

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Mnemosyne Pharmaceuticals Inc Form D Filing — $11,384,496 | FilingFlow